ArticleAnnals of translational medicine2023

Challenges for clinical application of "TRACEBACK" study: testing of historical Tubo-Ovarian cancer patients for hereditary risk genes.

Masayuki Sekine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.